Nonclonal chromosomal alterations and poor survival in cytopenic patients without hematological malignancies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8166
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nonclonal chromosomal alterations and poor survival in cytopenic patients without hematological malignancies ; volume:12 ; number:1 ; day:12 ; month:11 ; year:2019 ; pages:1-5 ; date:12.2019
Molecular cytogenetics ; 12, Heft 1 (12.11.2019), 1-5, 12.2019
- Urheber
-
Imataki, Osamu
Kubo, Hiroyuki
Takeuchi, Akihiro
Uemura, Makiko
Kadowaki, Norimitsu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13039-019-0458-9
- URN
-
urn:nbn:de:101:1-2020031000582663572071
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Imataki, Osamu
- Kubo, Hiroyuki
- Takeuchi, Akihiro
- Uemura, Makiko
- Kadowaki, Norimitsu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting splicing for hematological malignancies therapy
Targeting posttranslational modifications to treat hematological malignancies
Pulmonary involvement in patients with hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting splicing for hematological malignancies therapy
Targeting posttranslational modifications to treat hematological malignancies
Pulmonary involvement in patients with hematological malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Role of CD47 in Hematological Malignancies
Targeting splicing for hematological malignancies therapy
Targeting posttranslational modifications to treat hematological malignancies